Global Premenstrual Dysphoric Disorder (PMDD) Market Growth (Status and Outlook) 2025-2031
According to this study, the global Premenstrual Dysphoric Disorder (PMDD) market size will reach US$ million by 2031.
Premenstrual dysphoric disorder (PMDD) is a health problem that is similar to premenstrual syndrome (PMS) but is more serious. PMDD causes severe irritability, depression, or anxiety in the week or two before your period starts. Symptoms usually go away two to three days after your period starts.
United States market for Premenstrual Dysphoric Disorder (PMDD) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Premenstrual Dysphoric Disorder (PMDD) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Premenstrual Dysphoric Disorder (PMDD) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Premenstrual Dysphoric Disorder (PMDD) players cover Teva, Eli Liliy, Pfizer, Bayer, GSK, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Premenstrual Dysphoric Disorder (PMDD) Industry Forecast” looks at past sales and reviews total world Premenstrual Dysphoric Disorder (PMDD) sales in 2024, providing a comprehensive analysis by region and market sector of projected Premenstrual Dysphoric Disorder (PMDD) sales for 2025 through 2031. With Premenstrual Dysphoric Disorder (PMDD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Premenstrual Dysphoric Disorder (PMDD) industry.
This Insight Report provides a comprehensive analysis of the global Premenstrual Dysphoric Disorder (PMDD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Premenstrual Dysphoric Disorder (PMDD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Premenstrual Dysphoric Disorder (PMDD) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Premenstrual Dysphoric Disorder (PMDD) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Premenstrual Dysphoric Disorder (PMDD).
This report presents a comprehensive overview, market shares, and growth opportunities of Premenstrual Dysphoric Disorder (PMDD) market by product type, application, key players and key regions and countries.
Segmentation by Type:
Premenstrual dysphoric disorder (PMDD) is a health problem that is similar to premenstrual syndrome (PMS) but is more serious. PMDD causes severe irritability, depression, or anxiety in the week or two before your period starts. Symptoms usually go away two to three days after your period starts.
United States market for Premenstrual Dysphoric Disorder (PMDD) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Premenstrual Dysphoric Disorder (PMDD) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Premenstrual Dysphoric Disorder (PMDD) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Premenstrual Dysphoric Disorder (PMDD) players cover Teva, Eli Liliy, Pfizer, Bayer, GSK, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Premenstrual Dysphoric Disorder (PMDD) Industry Forecast” looks at past sales and reviews total world Premenstrual Dysphoric Disorder (PMDD) sales in 2024, providing a comprehensive analysis by region and market sector of projected Premenstrual Dysphoric Disorder (PMDD) sales for 2025 through 2031. With Premenstrual Dysphoric Disorder (PMDD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Premenstrual Dysphoric Disorder (PMDD) industry.
This Insight Report provides a comprehensive analysis of the global Premenstrual Dysphoric Disorder (PMDD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Premenstrual Dysphoric Disorder (PMDD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Premenstrual Dysphoric Disorder (PMDD) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Premenstrual Dysphoric Disorder (PMDD) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Premenstrual Dysphoric Disorder (PMDD).
This report presents a comprehensive overview, market shares, and growth opportunities of Premenstrual Dysphoric Disorder (PMDD) market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Table Product
- Inject Product
- Others
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Teva
- Eli Liliy
- Pfizer
- Bayer
- GSK
- Apotex
- Bristol Laboratories
- Mylan
- Allergan
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Size (2020-2031)
2.1.2 Premenstrual Dysphoric Disorder (PMDD) Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Premenstrual Dysphoric Disorder (PMDD) by Country/Region (2020, 2024 & 2031)
2.2 Premenstrual Dysphoric Disorder (PMDD) Segment by Type
2.2.1 Table Product
2.2.2 Inject Product
2.2.3 Others
2.3 Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
2.3.1 Premenstrual Dysphoric Disorder (PMDD) Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Type (2020-2025)
2.4 Premenstrual Dysphoric Disorder (PMDD) Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Premenstrual Dysphoric Disorder (PMDD) Market Size by Application
2.5.1 Premenstrual Dysphoric Disorder (PMDD) Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application (2020-2025)
3 PREMENSTRUAL DYSPHORIC DISORDER (PMDD) MARKET SIZE BY PLAYER
3.1 Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Player
3.1.1 Global Premenstrual Dysphoric Disorder (PMDD) Revenue by Player (2020-2025)
3.1.2 Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Player (2020-2025)
3.2 Global Premenstrual Dysphoric Disorder (PMDD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PREMENSTRUAL DYSPHORIC DISORDER (PMDD) BY REGION
4.1 Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (2020-2025)
4.2 Global Premenstrual Dysphoric Disorder (PMDD) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Premenstrual Dysphoric Disorder (PMDD) Market Size Growth (2020-2025)
4.4 APAC Premenstrual Dysphoric Disorder (PMDD) Market Size Growth (2020-2025)
4.5 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size Growth (2020-2025)
4.6 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2020-2025)
5.2 Americas Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2020-2025)
5.3 Americas Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (2020-2025)
6.2 APAC Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2020-2025)
6.3 APAC Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2020-2025)
7.2 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2020-2025)
7.3 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) by Region (2020-2025)
8.2 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2020-2025)
8.3 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PREMENSTRUAL DYSPHORIC DISORDER (PMDD) MARKET FORECAST
10.1 Global Premenstrual Dysphoric Disorder (PMDD) Forecast by Region (2026-2031)
10.1.1 Global Premenstrual Dysphoric Disorder (PMDD) Forecast by Region (2026-2031)
10.1.2 Americas Premenstrual Dysphoric Disorder (PMDD) Forecast
10.1.3 APAC Premenstrual Dysphoric Disorder (PMDD) Forecast
10.1.4 Europe Premenstrual Dysphoric Disorder (PMDD) Forecast
10.1.5 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Forecast
10.2 Americas Premenstrual Dysphoric Disorder (PMDD) Forecast by Country (2026-2031)
10.2.1 United States Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.2.2 Canada Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.2.3 Mexico Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.2.4 Brazil Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.3 APAC Premenstrual Dysphoric Disorder (PMDD) Forecast by Region (2026-2031)
10.3.1 China Premenstrual Dysphoric Disorder (PMDD) Market Forecast
10.3.2 Japan Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.3.3 Korea Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.3.4 Southeast Asia Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.3.5 India Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.3.6 Australia Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.4 Europe Premenstrual Dysphoric Disorder (PMDD) Forecast by Country (2026-2031)
10.4.1 Germany Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.4.2 France Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.4.3 UK Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.4.4 Italy Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.4.5 Russia Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.5 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Forecast by Region (2026-2031)
10.5.1 Egypt Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.5.2 South Africa Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.5.3 Israel Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.5.4 Turkey Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.6 Global Premenstrual Dysphoric Disorder (PMDD) Forecast by Type (2026-2031)
10.7 Global Premenstrual Dysphoric Disorder (PMDD) Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Premenstrual Dysphoric Disorder (PMDD) Forecast
11 KEY PLAYERS ANALYSIS
11.1 Teva
11.1.1 Teva Company Information
11.1.2 Teva Premenstrual Dysphoric Disorder (PMDD) Product Offered
11.1.3 Teva Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Teva Main Business Overview
11.1.5 Teva Latest Developments
11.2 Eli Liliy
11.2.1 Eli Liliy Company Information
11.2.2 Eli Liliy Premenstrual Dysphoric Disorder (PMDD) Product Offered
11.2.3 Eli Liliy Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Eli Liliy Main Business Overview
11.2.5 Eli Liliy Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Premenstrual Dysphoric Disorder (PMDD) Product Offered
11.3.3 Pfizer Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Bayer
11.4.1 Bayer Company Information
11.4.2 Bayer Premenstrual Dysphoric Disorder (PMDD) Product Offered
11.4.3 Bayer Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Bayer Main Business Overview
11.4.5 Bayer Latest Developments
11.5 GSK
11.5.1 GSK Company Information
11.5.2 GSK Premenstrual Dysphoric Disorder (PMDD) Product Offered
11.5.3 GSK Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 GSK Main Business Overview
11.5.5 GSK Latest Developments
11.6 Apotex
11.6.1 Apotex Company Information
11.6.2 Apotex Premenstrual Dysphoric Disorder (PMDD) Product Offered
11.6.3 Apotex Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Apotex Main Business Overview
11.6.5 Apotex Latest Developments
11.7 Bristol Laboratories
11.7.1 Bristol Laboratories Company Information
11.7.2 Bristol Laboratories Premenstrual Dysphoric Disorder (PMDD) Product Offered
11.7.3 Bristol Laboratories Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Bristol Laboratories Main Business Overview
11.7.5 Bristol Laboratories Latest Developments
11.8 Mylan
11.8.1 Mylan Company Information
11.8.2 Mylan Premenstrual Dysphoric Disorder (PMDD) Product Offered
11.8.3 Mylan Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Mylan Main Business Overview
11.8.5 Mylan Latest Developments
11.9 Allergan
11.9.1 Allergan Company Information
11.9.2 Allergan Premenstrual Dysphoric Disorder (PMDD) Product Offered
11.9.3 Allergan Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Allergan Main Business Overview
11.9.5 Allergan Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Size (2020-2031)
2.1.2 Premenstrual Dysphoric Disorder (PMDD) Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Premenstrual Dysphoric Disorder (PMDD) by Country/Region (2020, 2024 & 2031)
2.2 Premenstrual Dysphoric Disorder (PMDD) Segment by Type
2.2.1 Table Product
2.2.2 Inject Product
2.2.3 Others
2.3 Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
2.3.1 Premenstrual Dysphoric Disorder (PMDD) Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Type (2020-2025)
2.4 Premenstrual Dysphoric Disorder (PMDD) Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Premenstrual Dysphoric Disorder (PMDD) Market Size by Application
2.5.1 Premenstrual Dysphoric Disorder (PMDD) Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application (2020-2025)
3 PREMENSTRUAL DYSPHORIC DISORDER (PMDD) MARKET SIZE BY PLAYER
3.1 Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Player
3.1.1 Global Premenstrual Dysphoric Disorder (PMDD) Revenue by Player (2020-2025)
3.1.2 Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Player (2020-2025)
3.2 Global Premenstrual Dysphoric Disorder (PMDD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PREMENSTRUAL DYSPHORIC DISORDER (PMDD) BY REGION
4.1 Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (2020-2025)
4.2 Global Premenstrual Dysphoric Disorder (PMDD) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Premenstrual Dysphoric Disorder (PMDD) Market Size Growth (2020-2025)
4.4 APAC Premenstrual Dysphoric Disorder (PMDD) Market Size Growth (2020-2025)
4.5 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size Growth (2020-2025)
4.6 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2020-2025)
5.2 Americas Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2020-2025)
5.3 Americas Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (2020-2025)
6.2 APAC Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2020-2025)
6.3 APAC Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2020-2025)
7.2 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2020-2025)
7.3 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) by Region (2020-2025)
8.2 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2020-2025)
8.3 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PREMENSTRUAL DYSPHORIC DISORDER (PMDD) MARKET FORECAST
10.1 Global Premenstrual Dysphoric Disorder (PMDD) Forecast by Region (2026-2031)
10.1.1 Global Premenstrual Dysphoric Disorder (PMDD) Forecast by Region (2026-2031)
10.1.2 Americas Premenstrual Dysphoric Disorder (PMDD) Forecast
10.1.3 APAC Premenstrual Dysphoric Disorder (PMDD) Forecast
10.1.4 Europe Premenstrual Dysphoric Disorder (PMDD) Forecast
10.1.5 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Forecast
10.2 Americas Premenstrual Dysphoric Disorder (PMDD) Forecast by Country (2026-2031)
10.2.1 United States Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.2.2 Canada Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.2.3 Mexico Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.2.4 Brazil Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.3 APAC Premenstrual Dysphoric Disorder (PMDD) Forecast by Region (2026-2031)
10.3.1 China Premenstrual Dysphoric Disorder (PMDD) Market Forecast
10.3.2 Japan Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.3.3 Korea Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.3.4 Southeast Asia Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.3.5 India Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.3.6 Australia Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.4 Europe Premenstrual Dysphoric Disorder (PMDD) Forecast by Country (2026-2031)
10.4.1 Germany Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.4.2 France Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.4.3 UK Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.4.4 Italy Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.4.5 Russia Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.5 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Forecast by Region (2026-2031)
10.5.1 Egypt Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.5.2 South Africa Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.5.3 Israel Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.5.4 Turkey Market Premenstrual Dysphoric Disorder (PMDD) Forecast
10.6 Global Premenstrual Dysphoric Disorder (PMDD) Forecast by Type (2026-2031)
10.7 Global Premenstrual Dysphoric Disorder (PMDD) Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Premenstrual Dysphoric Disorder (PMDD) Forecast
11 KEY PLAYERS ANALYSIS
11.1 Teva
11.1.1 Teva Company Information
11.1.2 Teva Premenstrual Dysphoric Disorder (PMDD) Product Offered
11.1.3 Teva Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Teva Main Business Overview
11.1.5 Teva Latest Developments
11.2 Eli Liliy
11.2.1 Eli Liliy Company Information
11.2.2 Eli Liliy Premenstrual Dysphoric Disorder (PMDD) Product Offered
11.2.3 Eli Liliy Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Eli Liliy Main Business Overview
11.2.5 Eli Liliy Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Premenstrual Dysphoric Disorder (PMDD) Product Offered
11.3.3 Pfizer Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Bayer
11.4.1 Bayer Company Information
11.4.2 Bayer Premenstrual Dysphoric Disorder (PMDD) Product Offered
11.4.3 Bayer Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Bayer Main Business Overview
11.4.5 Bayer Latest Developments
11.5 GSK
11.5.1 GSK Company Information
11.5.2 GSK Premenstrual Dysphoric Disorder (PMDD) Product Offered
11.5.3 GSK Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 GSK Main Business Overview
11.5.5 GSK Latest Developments
11.6 Apotex
11.6.1 Apotex Company Information
11.6.2 Apotex Premenstrual Dysphoric Disorder (PMDD) Product Offered
11.6.3 Apotex Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Apotex Main Business Overview
11.6.5 Apotex Latest Developments
11.7 Bristol Laboratories
11.7.1 Bristol Laboratories Company Information
11.7.2 Bristol Laboratories Premenstrual Dysphoric Disorder (PMDD) Product Offered
11.7.3 Bristol Laboratories Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Bristol Laboratories Main Business Overview
11.7.5 Bristol Laboratories Latest Developments
11.8 Mylan
11.8.1 Mylan Company Information
11.8.2 Mylan Premenstrual Dysphoric Disorder (PMDD) Product Offered
11.8.3 Mylan Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Mylan Main Business Overview
11.8.5 Mylan Latest Developments
11.9 Allergan
11.9.1 Allergan Company Information
11.9.2 Allergan Premenstrual Dysphoric Disorder (PMDD) Product Offered
11.9.3 Allergan Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Allergan Main Business Overview
11.9.5 Allergan Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Premenstrual Dysphoric Disorder (PMDD) Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Premenstrual Dysphoric Disorder (PMDD) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTable Product
Table 4. Major Players of Inject Product
Table 5. Major Players of Others
Table 6. Premenstrual Dysphoric Disorder (PMDD) Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Type (2020-2025)
Table 9. Premenstrual Dysphoric Disorder (PMDD) Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application (2020-2025)
Table 12. Global Premenstrual Dysphoric Disorder (PMDD) Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Player (2020-2025)
Table 14. Premenstrual Dysphoric Disorder (PMDD) Key Players Head office and Products Offered
Table 15. Premenstrual Dysphoric Disorder (PMDD) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Region (2020-2025)
Table 20. Global Premenstrual Dysphoric Disorder (PMDD) Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Country (2020-2025)
Table 24. Americas Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Type (2020-2025)
Table 26. Americas Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application (2020-2025)
Table 28. APAC Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Region (2020-2025)
Table 30. APAC Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Country (2020-2025)
Table 34. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Premenstrual Dysphoric Disorder (PMDD)
Table 40. Key Market Challenges & Risks of Premenstrual Dysphoric Disorder (PMDD)
Table 41. Key Industry Trends of Premenstrual Dysphoric Disorder (PMDD)
Table 42. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Teva Details, Company Type, Premenstrual Dysphoric Disorder (PMDD) Area Served and Its Competitors
Table 47. Teva Premenstrual Dysphoric Disorder (PMDD) Product Offered
Table 48. Teva Premenstrual Dysphoric Disorder (PMDD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Teva Main Business
Table 50. Teva Latest Developments
Table 51. Eli Liliy Details, Company Type, Premenstrual Dysphoric Disorder (PMDD) Area Served and Its Competitors
Table 52. Eli Liliy Premenstrual Dysphoric Disorder (PMDD) Product Offered
Table 53. Eli Liliy Premenstrual Dysphoric Disorder (PMDD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Eli Liliy Main Business
Table 55. Eli Liliy Latest Developments
Table 56. Pfizer Details, Company Type, Premenstrual Dysphoric Disorder (PMDD) Area Served and Its Competitors
Table 57. Pfizer Premenstrual Dysphoric Disorder (PMDD) Product Offered
Table 58. Pfizer Premenstrual Dysphoric Disorder (PMDD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Pfizer Main Business
Table 60. Pfizer Latest Developments
Table 61. Bayer Details, Company Type, Premenstrual Dysphoric Disorder (PMDD) Area Served and Its Competitors
Table 62. Bayer Premenstrual Dysphoric Disorder (PMDD) Product Offered
Table 63. Bayer Premenstrual Dysphoric Disorder (PMDD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Bayer Main Business
Table 65. Bayer Latest Developments
Table 66. GSK Details, Company Type, Premenstrual Dysphoric Disorder (PMDD) Area Served and Its Competitors
Table 67. GSK Premenstrual Dysphoric Disorder (PMDD) Product Offered
Table 68. GSK Premenstrual Dysphoric Disorder (PMDD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. GSK Main Business
Table 70. GSK Latest Developments
Table 71. Apotex Details, Company Type, Premenstrual Dysphoric Disorder (PMDD) Area Served and Its Competitors
Table 72. Apotex Premenstrual Dysphoric Disorder (PMDD) Product Offered
Table 73. Apotex Premenstrual Dysphoric Disorder (PMDD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Apotex Main Business
Table 75. Apotex Latest Developments
Table 76. Bristol Laboratories Details, Company Type, Premenstrual Dysphoric Disorder (PMDD) Area Served and Its Competitors
Table 77. Bristol Laboratories Premenstrual Dysphoric Disorder (PMDD) Product Offered
Table 78. Bristol Laboratories Premenstrual Dysphoric Disorder (PMDD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Bristol Laboratories Main Business
Table 80. Bristol Laboratories Latest Developments
Table 81. Mylan Details, Company Type, Premenstrual Dysphoric Disorder (PMDD) Area Served and Its Competitors
Table 82. Mylan Premenstrual Dysphoric Disorder (PMDD) Product Offered
Table 83. Mylan Premenstrual Dysphoric Disorder (PMDD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Mylan Main Business
Table 85. Mylan Latest Developments
Table 86. Allergan Details, Company Type, Premenstrual Dysphoric Disorder (PMDD) Area Served and Its Competitors
Table 87. Allergan Premenstrual Dysphoric Disorder (PMDD) Product Offered
Table 88. Allergan Premenstrual Dysphoric Disorder (PMDD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Allergan Main Business
Table 90. Allergan Latest Developments
Table 1. Premenstrual Dysphoric Disorder (PMDD) Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Premenstrual Dysphoric Disorder (PMDD) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTable Product
Table 4. Major Players of Inject Product
Table 5. Major Players of Others
Table 6. Premenstrual Dysphoric Disorder (PMDD) Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Type (2020-2025)
Table 9. Premenstrual Dysphoric Disorder (PMDD) Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application (2020-2025)
Table 12. Global Premenstrual Dysphoric Disorder (PMDD) Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Player (2020-2025)
Table 14. Premenstrual Dysphoric Disorder (PMDD) Key Players Head office and Products Offered
Table 15. Premenstrual Dysphoric Disorder (PMDD) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Region (2020-2025)
Table 20. Global Premenstrual Dysphoric Disorder (PMDD) Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Country (2020-2025)
Table 24. Americas Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Type (2020-2025)
Table 26. Americas Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application (2020-2025)
Table 28. APAC Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Region (2020-2025)
Table 30. APAC Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Country (2020-2025)
Table 34. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Premenstrual Dysphoric Disorder (PMDD)
Table 40. Key Market Challenges & Risks of Premenstrual Dysphoric Disorder (PMDD)
Table 41. Key Industry Trends of Premenstrual Dysphoric Disorder (PMDD)
Table 42. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Teva Details, Company Type, Premenstrual Dysphoric Disorder (PMDD) Area Served and Its Competitors
Table 47. Teva Premenstrual Dysphoric Disorder (PMDD) Product Offered
Table 48. Teva Premenstrual Dysphoric Disorder (PMDD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Teva Main Business
Table 50. Teva Latest Developments
Table 51. Eli Liliy Details, Company Type, Premenstrual Dysphoric Disorder (PMDD) Area Served and Its Competitors
Table 52. Eli Liliy Premenstrual Dysphoric Disorder (PMDD) Product Offered
Table 53. Eli Liliy Premenstrual Dysphoric Disorder (PMDD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Eli Liliy Main Business
Table 55. Eli Liliy Latest Developments
Table 56. Pfizer Details, Company Type, Premenstrual Dysphoric Disorder (PMDD) Area Served and Its Competitors
Table 57. Pfizer Premenstrual Dysphoric Disorder (PMDD) Product Offered
Table 58. Pfizer Premenstrual Dysphoric Disorder (PMDD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Pfizer Main Business
Table 60. Pfizer Latest Developments
Table 61. Bayer Details, Company Type, Premenstrual Dysphoric Disorder (PMDD) Area Served and Its Competitors
Table 62. Bayer Premenstrual Dysphoric Disorder (PMDD) Product Offered
Table 63. Bayer Premenstrual Dysphoric Disorder (PMDD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Bayer Main Business
Table 65. Bayer Latest Developments
Table 66. GSK Details, Company Type, Premenstrual Dysphoric Disorder (PMDD) Area Served and Its Competitors
Table 67. GSK Premenstrual Dysphoric Disorder (PMDD) Product Offered
Table 68. GSK Premenstrual Dysphoric Disorder (PMDD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. GSK Main Business
Table 70. GSK Latest Developments
Table 71. Apotex Details, Company Type, Premenstrual Dysphoric Disorder (PMDD) Area Served and Its Competitors
Table 72. Apotex Premenstrual Dysphoric Disorder (PMDD) Product Offered
Table 73. Apotex Premenstrual Dysphoric Disorder (PMDD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Apotex Main Business
Table 75. Apotex Latest Developments
Table 76. Bristol Laboratories Details, Company Type, Premenstrual Dysphoric Disorder (PMDD) Area Served and Its Competitors
Table 77. Bristol Laboratories Premenstrual Dysphoric Disorder (PMDD) Product Offered
Table 78. Bristol Laboratories Premenstrual Dysphoric Disorder (PMDD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Bristol Laboratories Main Business
Table 80. Bristol Laboratories Latest Developments
Table 81. Mylan Details, Company Type, Premenstrual Dysphoric Disorder (PMDD) Area Served and Its Competitors
Table 82. Mylan Premenstrual Dysphoric Disorder (PMDD) Product Offered
Table 83. Mylan Premenstrual Dysphoric Disorder (PMDD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Mylan Main Business
Table 85. Mylan Latest Developments
Table 86. Allergan Details, Company Type, Premenstrual Dysphoric Disorder (PMDD) Area Served and Its Competitors
Table 87. Allergan Premenstrual Dysphoric Disorder (PMDD) Product Offered
Table 88. Allergan Premenstrual Dysphoric Disorder (PMDD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Allergan Main Business
Table 90. Allergan Latest Developments
LIST OF FIGURES
Figure 1. Premenstrual Dysphoric Disorder (PMDD) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Premenstrual Dysphoric Disorder (PMDD) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Premenstrual Dysphoric Disorder (PMDD) Sales Market Share by Country/Region (2024)
Figure 8. Premenstrual Dysphoric Disorder (PMDD) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Type in 2024
Figure 10. Premenstrual Dysphoric Disorder (PMDD) in Hospital
Figure 11. Global Premenstrual Dysphoric Disorder (PMDD) Market: Hospital (2020-2025) & ($ millions)
Figure 12. Premenstrual Dysphoric Disorder (PMDD) in Clinic
Figure 13. Global Premenstrual Dysphoric Disorder (PMDD) Market: Clinic (2020-2025) & ($ millions)
Figure 14. Premenstrual Dysphoric Disorder (PMDD) in Others
Figure 15. Global Premenstrual Dysphoric Disorder (PMDD) Market: Others (2020-2025) & ($ millions)
Figure 16. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application in 2024
Figure 17. Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Player in 2024
Figure 18. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Region (2020-2025)
Figure 19. Americas Premenstrual Dysphoric Disorder (PMDD) Market Size 2020-2025 ($ millions)
Figure 20. APAC Premenstrual Dysphoric Disorder (PMDD) Market Size 2020-2025 ($ millions)
Figure 21. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size 2020-2025 ($ millions)
Figure 23. Americas Premenstrual Dysphoric Disorder (PMDD) Value Market Share by Country in 2024
Figure 24. United States Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Region in 2024
Figure 29. APAC Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Type (2020-2025)
Figure 30. APAC Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application (2020-2025)
Figure 31. China Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 35. India Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Country in 2024
Figure 38. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Type (2020-2025)
Figure 39. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application (2020-2025)
Figure 40. Germany Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 41. France Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 54. APAC Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 55. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 57. United States Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 58. Canada Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 59. Mexico Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 60. Brazil Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 61. China Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 62. Japan Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 63. Korea Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 65. India Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 66. Australia Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 67. Germany Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 68. France Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 69. UK Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 70. Italy Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 71. Russia Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 72. Egypt Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 73. South Africa Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 74. Israel Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 75. Turkey Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 76. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 1. Premenstrual Dysphoric Disorder (PMDD) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Premenstrual Dysphoric Disorder (PMDD) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Premenstrual Dysphoric Disorder (PMDD) Sales Market Share by Country/Region (2024)
Figure 8. Premenstrual Dysphoric Disorder (PMDD) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Type in 2024
Figure 10. Premenstrual Dysphoric Disorder (PMDD) in Hospital
Figure 11. Global Premenstrual Dysphoric Disorder (PMDD) Market: Hospital (2020-2025) & ($ millions)
Figure 12. Premenstrual Dysphoric Disorder (PMDD) in Clinic
Figure 13. Global Premenstrual Dysphoric Disorder (PMDD) Market: Clinic (2020-2025) & ($ millions)
Figure 14. Premenstrual Dysphoric Disorder (PMDD) in Others
Figure 15. Global Premenstrual Dysphoric Disorder (PMDD) Market: Others (2020-2025) & ($ millions)
Figure 16. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application in 2024
Figure 17. Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Player in 2024
Figure 18. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Region (2020-2025)
Figure 19. Americas Premenstrual Dysphoric Disorder (PMDD) Market Size 2020-2025 ($ millions)
Figure 20. APAC Premenstrual Dysphoric Disorder (PMDD) Market Size 2020-2025 ($ millions)
Figure 21. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size 2020-2025 ($ millions)
Figure 23. Americas Premenstrual Dysphoric Disorder (PMDD) Value Market Share by Country in 2024
Figure 24. United States Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Region in 2024
Figure 29. APAC Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Type (2020-2025)
Figure 30. APAC Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application (2020-2025)
Figure 31. China Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 35. India Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Country in 2024
Figure 38. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Type (2020-2025)
Figure 39. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application (2020-2025)
Figure 40. Germany Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 41. France Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 54. APAC Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 55. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 57. United States Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 58. Canada Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 59. Mexico Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 60. Brazil Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 61. China Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 62. Japan Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 63. Korea Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 65. India Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 66. Australia Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 67. Germany Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 68. France Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 69. UK Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 70. Italy Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 71. Russia Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 72. Egypt Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 73. South Africa Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 74. Israel Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 75. Turkey Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
Figure 76. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Premenstrual Dysphoric Disorder (PMDD) Market Size 2026-2031 ($ millions)
